[Advantages and drawbacks of human insulin]

Area of Science:

• Immunology
• Endocrinology
• Pharmacology

Context:

• Traditional insulin preparations contained protein contaminants causing immunogenic side effects like lipodystrophy and insulin resistance.
• Monocomponent insulin (MC-I) and human insulin (HI) have significantly reduced these contaminants and associated adverse reactions.
• HI is the least immunogenic insulin, though its clinical advantages over MC-I are limited in some aspects.

Purpose:

• To evaluate the immunogenic and clinical implications of using human insulin (HI) compared to monocomponent insulin (MC-I).
• To assess the impact of maternal insulin antibody formation on fetal outcomes in diabetic pregnancies.
• To recommend optimal insulin therapy for women with diabetes during their childbearing years.

Summary:

• HI is virtually free of protein contaminants, minimizing immunologic side effects compared to older insulin preparations.
• Maternal antibodies to insulin can affect fetal outcomes; HI use in diabetic mothers is linked to lower rates of fetal macrosomia.
• While HI offers limited improvement in metabolic control and may alter hypoglycemia symptom perception, its reduced immunogenicity and benefits in pregnancy are significant.

Impact:

• Recommends HI for women with diabetes before and during pregnancy to improve fetal outcomes.
• Highlights the importance of insulin's immunogenic profile in managing diabetes, particularly in pregnancy.
• Suggests further investigation into the reasons for altered hypoglycemia symptom perception in patients treated with HI.